Schedule 13G ownership disclosure

ASLAN PHARMACEUTICALS LT ADR

Ordinary Shares as represented by American Depository Shares (ADSs),par value $0.01 per ordinary share · CUSIP: 04522R309

Event date: 2024-06-30

Filing-level shares
Unavailable
Percent of class
Unavailable
  • UBS Group AG

    Shares: Unavailable · Class: Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001610520-24-000138
Form type
SCHEDULE 13G/A
Filer
ASLAN Pharmaceuticals Ltd
CIK
CIK 1722926
Filed
Aug 08, 2024
Reporting period
Jun 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub